Fairholme Doubles Down on AIG Amid Continued Outflows
Manager exits at Columbia and John Hancock could signal more change for funds.
Fairholme Fund (FAIRX) manager Bruce Berkowitz had said that he would add to the fund's position in insurer American International Group (AIG) when the company issued new shares in May, and he wasn't kidding. Fairholme's May 31 portfolio reveals that Berkowitz more than doubled the fund's AIG position to 18.2% of assets, including warrants. (As a nondiversified fund, Fairholme is free to invest more than 5% of assets in a given company.)
That's relatively conservative, though, compared with the concentrated bets in the May 31 portfolios of smaller siblings Fairholme Allocation (FAAFX) and Fairholme Focused Income (FOCIX). Allocation, which is even less constrained than its larger sibling, has 27% of its assets in bond insurer MBIA (MBI) and 23.6% in AIG. Focused Income has 23.9% of its portfolio in various MBIA bonds. Both funds have about 15% of assets in cash.
Susan Daker does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.